Ophthalmic manifestations in patients with inflammatory bowel disease: a review
Clinical manifestations of inflammatory bowel disease(IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as...
Gespeichert in:
Veröffentlicht in: | World journal of gastroenterology : WJG 2017-08, Vol.23 (32), p.5836-5848 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 5848 |
---|---|
container_issue | 32 |
container_start_page | 5836 |
container_title | World journal of gastroenterology : WJG |
container_volume | 23 |
creator | Troncoso, Leandro Lopes Biancardi, Ana Luiza de Moraes, Jr, Haroldo Vieira Zaltman, Cyrla |
description | Clinical manifestations of inflammatory bowel disease(IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as episcleritis, uveitis and scleritis. A critical review of available literature concerning ocular involvement in IBD, as it appears in Pub Med, was performed. Episcleritis, the most common ocular extraintestinal manifestation(EIM), seems to be more associated with IBD activity when compared with other ocular EIMs. In IBD patients, anterior uveitis has an insidious onset, it is longstanding and bilateral, and not related to the intestinal disease activity. Systemic steroids or immunosuppressants may be necessary in severe ocular inflammation cases, and control of the underlying bowel disease is important to prevent recurrence. Our review revealed that ocular involvement is more prevalent in Crohn’s disease than ulcerative colitis, in active IBD, mainly in the presence of other EIMs. The ophthalmic symptoms in IBD are mainly nonspecific and their relevance may not be recognized by the clinician; most ophthalmic manifestations are treatable, and resolve without sequel upon prompt treatment. A collaborative clinical care team for management of IBD that includes ophthalmologists is central for improvement of quality care for these patients, and it is also cost-effective. |
doi_str_mv | 10.3748/wjg.v23.i32.5836 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5583569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90888889504849555150484851</cqvip_id><sourcerecordid>1941368684</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-a72f9b4bbbb06e964a9b8b14c87971fb41781e02361556e9aa746b1b5c405c853</originalsourceid><addsrcrecordid>eNpVUctOwzAQtBCIlsKdE8qRS4rfDw5IqOIlIfUCZ8sOTuMqids4bcTf40KpYC-72p0dj3cAuERwSgSVN8NyMd1iMvUET5kk_AiMMUYqx5LCYzBGEIpcESxG4CzGJYSYEIZPwQjL1IWCj8F8vqr6ytSNL7LGtL50sTe9D23MfJutUunaPmaD76vUKGvTNKYP3Wdmw-Dq7MNHZ6K7zUzWua13wzk4KU0d3cU-T8D748Pb7Dl_nT-9zO5f84JS2OdG4FJZalNA7hSnRllpES2kUAKVliIhkUt6OWIsAYwRlFtkWUEhKyQjE3D3w7va2MZ9FEllZ2q96nxjuk8djNf_J62v9CJsNUt3Ylwlgus9QRfWm_Rr3fhYuLo2rQubqJGiiHDJJU1Q-AMtuhBj58rDMwjqnQ86-aCTDzr5oHc-pJWrv_IOC7-HTwCy56xCu1j7dnHAKCh3oRikkirGGPquJEPkCzYclfQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1941368684</pqid></control><display><type>article</type><title>Ophthalmic manifestations in patients with inflammatory bowel disease: a review</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Troncoso, Leandro Lopes ; Biancardi, Ana Luiza ; de Moraes, Jr, Haroldo Vieira ; Zaltman, Cyrla</creator><creatorcontrib>Troncoso, Leandro Lopes ; Biancardi, Ana Luiza ; de Moraes, Jr, Haroldo Vieira ; Zaltman, Cyrla</creatorcontrib><description>Clinical manifestations of inflammatory bowel disease(IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as episcleritis, uveitis and scleritis. A critical review of available literature concerning ocular involvement in IBD, as it appears in Pub Med, was performed. Episcleritis, the most common ocular extraintestinal manifestation(EIM), seems to be more associated with IBD activity when compared with other ocular EIMs. In IBD patients, anterior uveitis has an insidious onset, it is longstanding and bilateral, and not related to the intestinal disease activity. Systemic steroids or immunosuppressants may be necessary in severe ocular inflammation cases, and control of the underlying bowel disease is important to prevent recurrence. Our review revealed that ocular involvement is more prevalent in Crohn’s disease than ulcerative colitis, in active IBD, mainly in the presence of other EIMs. The ophthalmic symptoms in IBD are mainly nonspecific and their relevance may not be recognized by the clinician; most ophthalmic manifestations are treatable, and resolve without sequel upon prompt treatment. A collaborative clinical care team for management of IBD that includes ophthalmologists is central for improvement of quality care for these patients, and it is also cost-effective.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v23.i32.5836</identifier><identifier>PMID: 28932076</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Gastroenterologists - organization & administration ; Immunosuppressive Agents - therapeutic use ; Inflammatory Bowel Diseases - complications ; Inflammatory Bowel Diseases - drug therapy ; Inflammatory Bowel Diseases - epidemiology ; Intersectoral Collaboration ; Ophthalmologists - organization & administration ; Patient Care Team - organization & administration ; Prevalence ; Recurrence ; Review ; Scleritis - drug therapy ; Scleritis - epidemiology ; Scleritis - etiology ; Uveitis - drug therapy ; Uveitis - epidemiology ; Uveitis - etiology</subject><ispartof>World journal of gastroenterology : WJG, 2017-08, Vol.23 (32), p.5836-5848</ispartof><rights>The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-a72f9b4bbbb06e964a9b8b14c87971fb41781e02361556e9aa746b1b5c405c853</citedby><cites>FETCH-LOGICAL-c440t-a72f9b4bbbb06e964a9b8b14c87971fb41781e02361556e9aa746b1b5c405c853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583569/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583569/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28932076$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Troncoso, Leandro Lopes</creatorcontrib><creatorcontrib>Biancardi, Ana Luiza</creatorcontrib><creatorcontrib>de Moraes, Jr, Haroldo Vieira</creatorcontrib><creatorcontrib>Zaltman, Cyrla</creatorcontrib><title>Ophthalmic manifestations in patients with inflammatory bowel disease: a review</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>Clinical manifestations of inflammatory bowel disease(IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as episcleritis, uveitis and scleritis. A critical review of available literature concerning ocular involvement in IBD, as it appears in Pub Med, was performed. Episcleritis, the most common ocular extraintestinal manifestation(EIM), seems to be more associated with IBD activity when compared with other ocular EIMs. In IBD patients, anterior uveitis has an insidious onset, it is longstanding and bilateral, and not related to the intestinal disease activity. Systemic steroids or immunosuppressants may be necessary in severe ocular inflammation cases, and control of the underlying bowel disease is important to prevent recurrence. Our review revealed that ocular involvement is more prevalent in Crohn’s disease than ulcerative colitis, in active IBD, mainly in the presence of other EIMs. The ophthalmic symptoms in IBD are mainly nonspecific and their relevance may not be recognized by the clinician; most ophthalmic manifestations are treatable, and resolve without sequel upon prompt treatment. A collaborative clinical care team for management of IBD that includes ophthalmologists is central for improvement of quality care for these patients, and it is also cost-effective.</description><subject>Gastroenterologists - organization & administration</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Inflammatory Bowel Diseases - complications</subject><subject>Inflammatory Bowel Diseases - drug therapy</subject><subject>Inflammatory Bowel Diseases - epidemiology</subject><subject>Intersectoral Collaboration</subject><subject>Ophthalmologists - organization & administration</subject><subject>Patient Care Team - organization & administration</subject><subject>Prevalence</subject><subject>Recurrence</subject><subject>Review</subject><subject>Scleritis - drug therapy</subject><subject>Scleritis - epidemiology</subject><subject>Scleritis - etiology</subject><subject>Uveitis - drug therapy</subject><subject>Uveitis - epidemiology</subject><subject>Uveitis - etiology</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUctOwzAQtBCIlsKdE8qRS4rfDw5IqOIlIfUCZ8sOTuMqids4bcTf40KpYC-72p0dj3cAuERwSgSVN8NyMd1iMvUET5kk_AiMMUYqx5LCYzBGEIpcESxG4CzGJYSYEIZPwQjL1IWCj8F8vqr6ytSNL7LGtL50sTe9D23MfJutUunaPmaD76vUKGvTNKYP3Wdmw-Dq7MNHZ6K7zUzWua13wzk4KU0d3cU-T8D748Pb7Dl_nT-9zO5f84JS2OdG4FJZalNA7hSnRllpES2kUAKVliIhkUt6OWIsAYwRlFtkWUEhKyQjE3D3w7va2MZ9FEllZ2q96nxjuk8djNf_J62v9CJsNUt3Ylwlgus9QRfWm_Rr3fhYuLo2rQubqJGiiHDJJU1Q-AMtuhBj58rDMwjqnQ86-aCTDzr5oHc-pJWrv_IOC7-HTwCy56xCu1j7dnHAKCh3oRikkirGGPquJEPkCzYclfQ</recordid><startdate>20170828</startdate><enddate>20170828</enddate><creator>Troncoso, Leandro Lopes</creator><creator>Biancardi, Ana Luiza</creator><creator>de Moraes, Jr, Haroldo Vieira</creator><creator>Zaltman, Cyrla</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170828</creationdate><title>Ophthalmic manifestations in patients with inflammatory bowel disease: a review</title><author>Troncoso, Leandro Lopes ; Biancardi, Ana Luiza ; de Moraes, Jr, Haroldo Vieira ; Zaltman, Cyrla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-a72f9b4bbbb06e964a9b8b14c87971fb41781e02361556e9aa746b1b5c405c853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Gastroenterologists - organization & administration</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Inflammatory Bowel Diseases - complications</topic><topic>Inflammatory Bowel Diseases - drug therapy</topic><topic>Inflammatory Bowel Diseases - epidemiology</topic><topic>Intersectoral Collaboration</topic><topic>Ophthalmologists - organization & administration</topic><topic>Patient Care Team - organization & administration</topic><topic>Prevalence</topic><topic>Recurrence</topic><topic>Review</topic><topic>Scleritis - drug therapy</topic><topic>Scleritis - epidemiology</topic><topic>Scleritis - etiology</topic><topic>Uveitis - drug therapy</topic><topic>Uveitis - epidemiology</topic><topic>Uveitis - etiology</topic><toplevel>online_resources</toplevel><creatorcontrib>Troncoso, Leandro Lopes</creatorcontrib><creatorcontrib>Biancardi, Ana Luiza</creatorcontrib><creatorcontrib>de Moraes, Jr, Haroldo Vieira</creatorcontrib><creatorcontrib>Zaltman, Cyrla</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Troncoso, Leandro Lopes</au><au>Biancardi, Ana Luiza</au><au>de Moraes, Jr, Haroldo Vieira</au><au>Zaltman, Cyrla</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ophthalmic manifestations in patients with inflammatory bowel disease: a review</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2017-08-28</date><risdate>2017</risdate><volume>23</volume><issue>32</issue><spage>5836</spage><epage>5848</epage><pages>5836-5848</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>Clinical manifestations of inflammatory bowel disease(IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as episcleritis, uveitis and scleritis. A critical review of available literature concerning ocular involvement in IBD, as it appears in Pub Med, was performed. Episcleritis, the most common ocular extraintestinal manifestation(EIM), seems to be more associated with IBD activity when compared with other ocular EIMs. In IBD patients, anterior uveitis has an insidious onset, it is longstanding and bilateral, and not related to the intestinal disease activity. Systemic steroids or immunosuppressants may be necessary in severe ocular inflammation cases, and control of the underlying bowel disease is important to prevent recurrence. Our review revealed that ocular involvement is more prevalent in Crohn’s disease than ulcerative colitis, in active IBD, mainly in the presence of other EIMs. The ophthalmic symptoms in IBD are mainly nonspecific and their relevance may not be recognized by the clinician; most ophthalmic manifestations are treatable, and resolve without sequel upon prompt treatment. A collaborative clinical care team for management of IBD that includes ophthalmologists is central for improvement of quality care for these patients, and it is also cost-effective.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>28932076</pmid><doi>10.3748/wjg.v23.i32.5836</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2017-08, Vol.23 (32), p.5836-5848 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5583569 |
source | MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Gastroenterologists - organization & administration Immunosuppressive Agents - therapeutic use Inflammatory Bowel Diseases - complications Inflammatory Bowel Diseases - drug therapy Inflammatory Bowel Diseases - epidemiology Intersectoral Collaboration Ophthalmologists - organization & administration Patient Care Team - organization & administration Prevalence Recurrence Review Scleritis - drug therapy Scleritis - epidemiology Scleritis - etiology Uveitis - drug therapy Uveitis - epidemiology Uveitis - etiology |
title | Ophthalmic manifestations in patients with inflammatory bowel disease: a review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T19%3A27%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ophthalmic%20manifestations%20in%20patients%20with%20inflammatory%20bowel%20disease:%20a%20review&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Troncoso,%20Leandro%20Lopes&rft.date=2017-08-28&rft.volume=23&rft.issue=32&rft.spage=5836&rft.epage=5848&rft.pages=5836-5848&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v23.i32.5836&rft_dat=%3Cproquest_pubme%3E1941368684%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1941368684&rft_id=info:pmid/28932076&rft_cqvip_id=90888889504849555150484851&rfr_iscdi=true |